Werner Spinner, a non-executive director at the stem cell bank group Cryo-Save, has topped up his stake in the company, taking about £20,000 worth of shares.
Spinner, who served for 30 years with the German drug giant Bayer, took 25,000 shares at 77.2p a time.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Cryo-Save, which has its headquarters in the Netherlands and stores more than 100,000 adult stem cells in storage facilities in Belgium, Germany and Dubai, last month reported a fall in full-year profits due to higher operating expenses, but said it was well positioned to capitalise on its international position.
Revenue was up 67% to €29.5m in the year ended 31 December, while pre-tax profit fell to €2.86m compared with €4.51m last time as operating expenses rose to €17.9m from €7.13m previously.
Top Director Buys
Value: £49,980
Value: £19,740
Value: £19,300
Value: $12,000
Value: £10,183
Top Director Sells
Value: £2,400,000
Value: £2,400,000
Value: £960,000
Value: £321,922
Value: £119,138
Value: £53,472
Value: £41,736
Value: £38,244
Value: £35,123
Value: £12,000
-
Autumn Budget 2025: What we know so farChancellor Rachel Reeves is set to announce a slew of new measures in her second Autumn Budget and an ailing economy means tax hikes are almost certain. Here's what we know so far, and what analysts are expecting.
-
Hundreds of thousands more taxpayers to be pulled into £100k ‘tax trap’ by 2029Frozen thresholds are pushing more workers into paying income tax at an effective 60% rate. We look at why, as well as how you can avoid being caught in the trap.
